Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Cash & Equivalents (2023 - 2025)

Vsee Health's Cash & Equivalents history spans 3 years, with the latest figure at $291595.0 for Q2 2025.

  • For Q2 2025, Cash & Equivalents changed N/A year-over-year to $291595.0; the TTM value through Jun 2025 reached $291595.0, changed N/A, while the annual FY2024 figure was $326115.0, 174.66% up from the prior year.
  • Cash & Equivalents reached $291595.0 in Q2 2025 per VSEE's latest filing, down from $326115.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $326115.0 in Q4 2024 to a low of $507.0 in Q3 2023.
  • Average Cash & Equivalents over 3 years is $153562.4, with a median of $118734.0 recorded in 2023.
  • The largest YoY upside for Cash & Equivalents was 174.66% in 2024 against a maximum downside of 174.66% in 2024.
  • A 3-year view of Cash & Equivalents shows it stood at $118734.0 in 2023, then surged by 174.66% to $326115.0 in 2024, then dropped by 10.59% to $291595.0 in 2025.
  • Per Business Quant, the three most recent readings for VSEE's Cash & Equivalents are $291595.0 (Q2 2025), $326115.0 (Q4 2024), and $118734.0 (Q4 2023).